Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)
This study is ongoing, but not recruiting participants.
Study NCT00239915.   Last updated on April 13, 2006.
Information provided by Pharmacology Research Institute
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Persistent Developmental Stuttering
Additional conditions recognized in this trial
Stuttering
More general conditions related to this trial
Communication Disorders
Language Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Speech Disorders
Interventions listed in this trial
Pagoclone
Sponsors listed in this trial
Pharmacology Research Institute


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services